Home » Authors » Trista Morrison

Articles by Trista Morrison

Spin-Out Sequel Pharma Closes $20M Series A

Sep. 28, 2007

By Trista Morrison

Spin-Out Sequel Pharma Closes $20M Series A

Sep. 28, 2007

By Trista Morrison

Partnering Tables Turn As Big Pharma Pitches Biotech

Sep. 27, 2007

By Trista Morrison

Partnering Tables Turn As Big Pharma Pitches Biotech

Sep. 27, 2007

By Trista Morrison

Embryonic Stem Cell Research Advances, But Obstacles Remain

Sep. 26, 2007

By Trista Morrison

Embryonic Stem Cell Research Advances, But Obstacles Remain

Sep. 26, 2007

By Trista Morrison

Virxsys Acquires Intronn, Gets RNA Payloads For Gene Therapy

Sep. 24, 2007

By Trista Morrison

Virxsys Acquires Intronn, Gets RNA Payloads For Gene Therapy

Sep. 24, 2007

By Trista Morrison

Progenics Raises $57M Publicly; Cellerix Gets $40M In Series B

Sep. 21, 2007

By Trista Morrison

NewCo News: ImmunoBiosciences Using ICV Platform To Improve Vaccines

Sep. 21, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...